Alkermes plc - Ordinary Shares (NQ:ALKS)

45.63 +0.27 (+0.58%)

Delayed Quote Updated: 10:44 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alkermes plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

NASDAQ:ALKS, an undervalued stock with good fundamentals. ↗

January 19, 2024

Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Cassava Sciences Stock Continues Showing Rising Relative Strength ↗

January 16, 2024

Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level.

Via Investor's Business Daily

Why the growth investor may take a look at ALKERMES PLC (NASDAQ:ALKS). ↗

January 16, 2024

High growth, ROE and beating expectations for NASDAQ:ALKS: growth investors may appreciate this.

Via Chartmill

The 3 Most Undervalued Biotech Stocks to Buy in January ↗

January 15, 2024

These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios.

Via InvestorPlace

NASDAQ:ALKS, a growth stock which is not overvalued. ↗

January 10, 2024

Investors seeking growth at a reasonable cost should explore NASDAQ:ALKS.

Via Chartmill

Decoding 5 Analyst Evaluations For Alkermes ↗

January 02, 2024

Via Benzinga

Delving into NASDAQ:ALKS's Growth Prospects. ↗

December 26, 2023

High growth, ROE and beating expectations for NASDAQ:ALKS: growth investors may appreciate this.

Via Chartmill

ALKERMES PLC (NASDAQ:ALKS) showing high EPS and FCF growth while beating expectations ↗

December 04, 2023

Why the growth investor may take a look at NASDAQ:ALKS.

Via Chartmill

Where Alkermes Stands With Analysts ↗

November 20, 2023

Via Benzinga

NASDAQ:ALKS: good value for what you're paying. ↗

November 16, 2023

Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.

Via Chartmill

For those who appreciate value investing, NASDAQ:ALKS is a compelling option with its solid fundamentals. ↗

December 28, 2023

Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents.

Via Chartmill

For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering. ↗

December 20, 2023

Looking for growth without the hefty price tag? Consider ALKERMES PLC (NASDAQ:ALKS).

Via Chartmill

When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗

December 07, 2023

ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

Uber Will Join The S&P 500 Index. The Stock Is Jumping. ↗

December 01, 2023

The ride-hailing giant will join the index as part of a quarterly rebalancing.

Via Investor's Business Daily

Topics Stocks

For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering. ↗

November 29, 2023

Investors seeking growth at a reasonable cost should explore NASDAQ:ALKS.

Via Chartmill

NASDAQ:ALKS—A High-Growth Stock Gearing Up for Its Next Upward Move. ↗

November 14, 2023

Is ALKERMES PLC (NASDAQ:ALKS) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

Why Alkermes Stock Is Sinking Today ↗

October 25, 2023

The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.

Via The Motley Fool

Why NASDAQ:ALKS Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

October 23, 2023

ALKERMES PLC (NASDAQ:ALKS), a strong growth stock, setting up for a breakout.

Via Chartmill

Why Is Mural Oncology (MURA) Stock Up 59% Today? ↗

November 17, 2023

Mural Oncology stock is climbing higher on Friday as the company's shares bounce back from a dip yesterday during its public debut.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 17, 2023

It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

3 Growth Stocks Set to Dominate the Decade ↗

November 14, 2023

Here are three growth stocks to buy that are poised to dominate the decade. Add them to your portfolio for long-term financial success.

Via InvestorPlace

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering. ↗

November 07, 2023

ALKERMES PLC (NASDAQ:ALKS) stands out as a growth opportunity that won't break the bank.

Via Chartmill

NASDAQ:ALKS, an undervalued stock with good fundamentals. ↗

October 26, 2023

ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook ↗

October 25, 2023

Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗

October 24, 2023

Via Benzinga

Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone. ↗

October 23, 2023

Analysts say Alkermes' drug is clearly active. But investors have concerns.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023 ↗

October 17, 2023

Via Benzinga

While growth is established for NASDAQ:ALKS, the stock's valuation remains reasonable. ↗

October 17, 2023

Looking for growth without the hefty price tag? Consider ALKERMES PLC (NASDAQ:ALKS).

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.